Cargando…

Systematic Pharmacogenomics Analysis of a Malay Whole Genome: Proof of Concept for Personalized Medicine

BACKGROUND: With a higher throughput and lower cost in sequencing, second generation sequencing technology has immense potential for translation into clinical practice and in the realization of pharmacogenomics based patient care. The systematic analysis of whole genome sequences to assess patient t...

Descripción completa

Detalles Bibliográficos
Autores principales: Salleh, Mohd Zaki, Teh, Lay Kek, Lee, Lian Shien, Ismet, Rose Iszati, Patowary, Ashok, Joshi, Kandarp, Pasha, Ayesha, Ahmed, Azni Zain, Janor, Roziah Mohd, Hamzah, Ahmad Sazali, Adam, Aishah, Yusoff, Khalid, Hoh, Boon Peng, Hatta, Fazleen Haslinda Mohd, Ismail, Mohamad Izwan, Scaria, Vinod, Sivasubbu, Sridhar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3751891/
https://www.ncbi.nlm.nih.gov/pubmed/24009664
http://dx.doi.org/10.1371/journal.pone.0071554
_version_ 1782281695060295680
author Salleh, Mohd Zaki
Teh, Lay Kek
Lee, Lian Shien
Ismet, Rose Iszati
Patowary, Ashok
Joshi, Kandarp
Pasha, Ayesha
Ahmed, Azni Zain
Janor, Roziah Mohd
Hamzah, Ahmad Sazali
Adam, Aishah
Yusoff, Khalid
Hoh, Boon Peng
Hatta, Fazleen Haslinda Mohd
Ismail, Mohamad Izwan
Scaria, Vinod
Sivasubbu, Sridhar
author_facet Salleh, Mohd Zaki
Teh, Lay Kek
Lee, Lian Shien
Ismet, Rose Iszati
Patowary, Ashok
Joshi, Kandarp
Pasha, Ayesha
Ahmed, Azni Zain
Janor, Roziah Mohd
Hamzah, Ahmad Sazali
Adam, Aishah
Yusoff, Khalid
Hoh, Boon Peng
Hatta, Fazleen Haslinda Mohd
Ismail, Mohamad Izwan
Scaria, Vinod
Sivasubbu, Sridhar
author_sort Salleh, Mohd Zaki
collection PubMed
description BACKGROUND: With a higher throughput and lower cost in sequencing, second generation sequencing technology has immense potential for translation into clinical practice and in the realization of pharmacogenomics based patient care. The systematic analysis of whole genome sequences to assess patient to patient variability in pharmacokinetics and pharmacodynamics responses towards drugs would be the next step in future medicine in line with the vision of personalizing medicine. METHODS: Genomic DNA obtained from a 55 years old, self-declared healthy, anonymous male of Malay descent was sequenced. The subject's mother died of lung cancer and the father had a history of schizophrenia and deceased at the age of 65 years old. A systematic, intuitive computational workflow/pipeline integrating custom algorithm in tandem with large datasets of variant annotations and gene functions for genetic variations with pharmacogenomics impact was developed. A comprehensive pathway map of drug transport, metabolism and action was used as a template to map non-synonymous variations with potential functional consequences. PRINCIPAL FINDINGS: Over 3 million known variations and 100,898 novel variations in the Malay genome were identified. Further in-depth pharmacogenetics analysis revealed a total of 607 unique variants in 563 proteins, with the eventual identification of 4 drug transport genes, 2 drug metabolizing enzyme genes and 33 target genes harboring deleterious SNVs involved in pharmacological pathways, which could have a potential role in clinical settings. CONCLUSIONS: The current study successfully unravels the potential of personal genome sequencing in understanding the functionally relevant variations with potential influence on drug transport, metabolism and differential therapeutic outcomes. These will be essential for realizing personalized medicine through the use of comprehensive computational pipeline for systematic data mining and analysis.
format Online
Article
Text
id pubmed-3751891
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-37518912013-09-05 Systematic Pharmacogenomics Analysis of a Malay Whole Genome: Proof of Concept for Personalized Medicine Salleh, Mohd Zaki Teh, Lay Kek Lee, Lian Shien Ismet, Rose Iszati Patowary, Ashok Joshi, Kandarp Pasha, Ayesha Ahmed, Azni Zain Janor, Roziah Mohd Hamzah, Ahmad Sazali Adam, Aishah Yusoff, Khalid Hoh, Boon Peng Hatta, Fazleen Haslinda Mohd Ismail, Mohamad Izwan Scaria, Vinod Sivasubbu, Sridhar PLoS One Research Article BACKGROUND: With a higher throughput and lower cost in sequencing, second generation sequencing technology has immense potential for translation into clinical practice and in the realization of pharmacogenomics based patient care. The systematic analysis of whole genome sequences to assess patient to patient variability in pharmacokinetics and pharmacodynamics responses towards drugs would be the next step in future medicine in line with the vision of personalizing medicine. METHODS: Genomic DNA obtained from a 55 years old, self-declared healthy, anonymous male of Malay descent was sequenced. The subject's mother died of lung cancer and the father had a history of schizophrenia and deceased at the age of 65 years old. A systematic, intuitive computational workflow/pipeline integrating custom algorithm in tandem with large datasets of variant annotations and gene functions for genetic variations with pharmacogenomics impact was developed. A comprehensive pathway map of drug transport, metabolism and action was used as a template to map non-synonymous variations with potential functional consequences. PRINCIPAL FINDINGS: Over 3 million known variations and 100,898 novel variations in the Malay genome were identified. Further in-depth pharmacogenetics analysis revealed a total of 607 unique variants in 563 proteins, with the eventual identification of 4 drug transport genes, 2 drug metabolizing enzyme genes and 33 target genes harboring deleterious SNVs involved in pharmacological pathways, which could have a potential role in clinical settings. CONCLUSIONS: The current study successfully unravels the potential of personal genome sequencing in understanding the functionally relevant variations with potential influence on drug transport, metabolism and differential therapeutic outcomes. These will be essential for realizing personalized medicine through the use of comprehensive computational pipeline for systematic data mining and analysis. Public Library of Science 2013-08-23 /pmc/articles/PMC3751891/ /pubmed/24009664 http://dx.doi.org/10.1371/journal.pone.0071554 Text en © 2013 Salleh et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Salleh, Mohd Zaki
Teh, Lay Kek
Lee, Lian Shien
Ismet, Rose Iszati
Patowary, Ashok
Joshi, Kandarp
Pasha, Ayesha
Ahmed, Azni Zain
Janor, Roziah Mohd
Hamzah, Ahmad Sazali
Adam, Aishah
Yusoff, Khalid
Hoh, Boon Peng
Hatta, Fazleen Haslinda Mohd
Ismail, Mohamad Izwan
Scaria, Vinod
Sivasubbu, Sridhar
Systematic Pharmacogenomics Analysis of a Malay Whole Genome: Proof of Concept for Personalized Medicine
title Systematic Pharmacogenomics Analysis of a Malay Whole Genome: Proof of Concept for Personalized Medicine
title_full Systematic Pharmacogenomics Analysis of a Malay Whole Genome: Proof of Concept for Personalized Medicine
title_fullStr Systematic Pharmacogenomics Analysis of a Malay Whole Genome: Proof of Concept for Personalized Medicine
title_full_unstemmed Systematic Pharmacogenomics Analysis of a Malay Whole Genome: Proof of Concept for Personalized Medicine
title_short Systematic Pharmacogenomics Analysis of a Malay Whole Genome: Proof of Concept for Personalized Medicine
title_sort systematic pharmacogenomics analysis of a malay whole genome: proof of concept for personalized medicine
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3751891/
https://www.ncbi.nlm.nih.gov/pubmed/24009664
http://dx.doi.org/10.1371/journal.pone.0071554
work_keys_str_mv AT sallehmohdzaki systematicpharmacogenomicsanalysisofamalaywholegenomeproofofconceptforpersonalizedmedicine
AT tehlaykek systematicpharmacogenomicsanalysisofamalaywholegenomeproofofconceptforpersonalizedmedicine
AT leelianshien systematicpharmacogenomicsanalysisofamalaywholegenomeproofofconceptforpersonalizedmedicine
AT ismetroseiszati systematicpharmacogenomicsanalysisofamalaywholegenomeproofofconceptforpersonalizedmedicine
AT patowaryashok systematicpharmacogenomicsanalysisofamalaywholegenomeproofofconceptforpersonalizedmedicine
AT joshikandarp systematicpharmacogenomicsanalysisofamalaywholegenomeproofofconceptforpersonalizedmedicine
AT pashaayesha systematicpharmacogenomicsanalysisofamalaywholegenomeproofofconceptforpersonalizedmedicine
AT ahmedaznizain systematicpharmacogenomicsanalysisofamalaywholegenomeproofofconceptforpersonalizedmedicine
AT janorroziahmohd systematicpharmacogenomicsanalysisofamalaywholegenomeproofofconceptforpersonalizedmedicine
AT hamzahahmadsazali systematicpharmacogenomicsanalysisofamalaywholegenomeproofofconceptforpersonalizedmedicine
AT adamaishah systematicpharmacogenomicsanalysisofamalaywholegenomeproofofconceptforpersonalizedmedicine
AT yusoffkhalid systematicpharmacogenomicsanalysisofamalaywholegenomeproofofconceptforpersonalizedmedicine
AT hohboonpeng systematicpharmacogenomicsanalysisofamalaywholegenomeproofofconceptforpersonalizedmedicine
AT hattafazleenhaslindamohd systematicpharmacogenomicsanalysisofamalaywholegenomeproofofconceptforpersonalizedmedicine
AT ismailmohamadizwan systematicpharmacogenomicsanalysisofamalaywholegenomeproofofconceptforpersonalizedmedicine
AT scariavinod systematicpharmacogenomicsanalysisofamalaywholegenomeproofofconceptforpersonalizedmedicine
AT sivasubbusridhar systematicpharmacogenomicsanalysisofamalaywholegenomeproofofconceptforpersonalizedmedicine